All Stories

  1. Will artificial intelligence be the answer for the gap in vulvovaginal diseases?
  2. Polymicrobial Consortia in the Pathogenesis of Biofilm Vaginosis Visualized by FISH. Historic Review Outlining the Basic Principles of the Polymicrobial Infection Theory
  3. Evaluation of Host Gene Methylation as a Triage Test for HPV–Positive Women—A Cohort Study
  4. The genital tract microbiome: bridging the gap between hype and clinical reality
  5. Genital tract microbiota composition profiles and use of prebiotics and probiotics in gynaecological cancer prevention: review of the current evidence, the European Society of Gynaecological Oncology prevention committee statement
  6. Chlamydial and Gonococcal Genital Infections: A Narrative Review
  7. Low genitourinary tract risks in women living with the human immunodeficiency virus
  8. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) Consensus St...
  9. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus st...
  10. Vulvar High-Grade Squamous Intraepithelial Lesion and the Risk of Recurrence and Progression to Cancer
  11. Scoping review of cytolytic vaginosis literature
  12. International Society for the Study of Vulvovaginal Disease Recommendations for the Diagnosis and Treatment of Vaginitis
  13. Chronic Hypertrophic Herpes Simplex Infection: A 13-Year Delay
  14. Therapeutic Options for Chlamydia trachomatis Infection: Present and Future
  15. Reply to De Giorgi et al. Comment on “Kesić et al. Early Diagnostics of Vulvar Intraepithelial Neoplasia. Cancers 2022, 14, 1822”
  16. Efficacy of Hormonal and Nonhormonal Approaches to Vaginal Atrophy and Sexual Dysfunctions in Postmenopausal Women: A Systematic Review
  17. Vulvar Paget's disease: outcomes of 51 patients treated with imiquimod cream
  18. Vaginal Leptothrix: An Innocent Bystander?
  19. Changes in the Vaginal Microbiota of Women With Secondary Localized Provoked Vulvodynia
  20. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus sta...
  21. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Sta...
  22. Early Diagnostics of Vulvar Intraepithelial Neoplasia
  23. Wet Mount Microscopy of the Vaginal Milieu Does Not Predict the Outcome of Fertility Treatments
  24. COVID-19 related acute genital ulcer: a case report
  25. The Vaginal Microbiome: I. Research Development, Lexicon, Defining “Normal” and the Dynamics Throughout Women's Lives
  26. The Vaginal Microbiome: II. Vaginal Dysbiotic Conditions
  27. The Vaginal Microbiome: III. The Vaginal Microbiome in Various Urogenital Disorders
  28. The Vaginal Microbiome: IV. The Role of Vaginal Microbiome in Reproduction and in Gynecologic Cancers
  29. The Vaginal Microbiome: V. Therapeutic Modalities of Vaginal Microbiome Engineering and Research Challenges
  30. Vulvar High-Grade Squamous Intraepithelial Lesions and Cancer as a Risk Factor for Anal Cancer: A Review
  31. Use of Moisturizers and Lubricants for Vulvovaginal Atrophy
  32. Hormonal Approach for Postmenopausal Vulvovaginal Atrophy
  33. Genitourinary Syndrome of Menopause: Epidemiology, Physiopathology, Clinical Manifestation and Diagnostic
  34. G-spot: Fact or Fiction?: A Systematic Review
  35. Superficially Invasive Vulvar Squamous Cell Carcinoma: A 37-Year-Long Experience of a Tertiary Referral Center
  36. Diagnosis of bacterial vaginosis: Clinical or microscopic? A cross‐sectional study
  37. Cytology Is Not Reliable to Evaluate Cervical Disease Regression
  38. Management of postmenopausal vulvovaginal atrophy: recommendations of the International Society for the Study of Vulvovaginal Disease
  39. Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy
  40. For Anal Cancer, Not All Women Are Equal
  41. Clinical validation of a new molecular test (Seegene Allplex™ Vaginitis) for the diagnosis of vaginitis: a cross‐sectional study
  42. Clarification about vulvar cancer precursor lesions
  43. The International Society for the Study of Vulvovaginal Disease Vaginal Wet Mount Microscopy Guidelines: How to Perform, Applications, and Interpretation
  44. Knowledge of Vulvar Anatomy and Self-examination in a Sample of Italian Women
  45. Letter to the editor: “Do variations in labial anatomy have an effect on recurrent urinary tract infection?”
  46. Erosive Vulvar Lichen Planus and Risk of Vulvar Neoplasia
  47. Prognostic factors for recurrence and survival in uncommon variants of vulvar cancer
  48. Cross-Protective IgG and IgA Antibodies against Oncogenic and Non-Oncogenic HPV Genotypes
  49. Impact of a High Coverage Vaccination Rate on Human Papillomavirus Infection Prevalence in Young Women: A Cross-sectional Study
  50. Better studies needed on LASER use in urinary incontinence
  51. Prognostic factors in patients with vulvar cancer: the VULCAN study
  52. Editorial Comment: The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document
  53. Better triage tests needed for HPV‐positive women
  54. Adult Vulvar Lichen Sclerosus: Can Experts Agree on the Assessment of Disease Severity?
  55. Corrigendum
  56. The International Classification of Diseases, 11th Revision: A Step-Back for Women With Vulvodynia?
  57. Diagnosis of vaginitis: time to improve and move on
  58. Response letter to comments related to “The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document”
  59. Systematic review and meta-analysis of the effects of treatment modalities for vestibulodynia in women
  60. Vulvodynia: a neglected chronic pain diagnosis
  61. Academic cosmetic gynaecology and energy-based therapies: ambiguities, explorations, and FDA advisories
  62. Descriptors of Vulvodynia: A Multisocietal Definition Consensus (International Society for the Study of Vulvovaginal Disease, the International Society for the Study of Women Sexual Health, and the International Pelvic Pain Society)
  63. Impact of the Sampling Site in the Result of Wet Mount Microscopy
  64. The Clinical Role of LASER for Vulvar and Vaginal Treatments in Gynecology and Female Urology: An ICS/ISSVD Best Practice Consensus Document
  65. The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document
  66. The energy based devices for vaginal “rejuvenation,” urinary incontinence, vaginal cosmetic procedures, and other vulvo‐vaginal disorders: An international multidisciplinary expert panel opinion
  67. Immediate Loop Electrode Excisional Procedure for High-Grade Cervical Cytology: One Size Fits All?
  68. Vulvodynia: A disease commonly hidden in plain sight
  69. International Society for the Study of Vulvovaginal Disease Recommendations Regarding Female Cosmetic Genital Surgery
  70. To the Editor:
  71. Bioengineering Organs for Blood Detoxification
  72. The ReCiDiF method to treat recurrent vulvovaginal candidosis: A friend with benefits
  73. Diagnosis and management of vulvodynia in postmenopausal women
  74. Aerobic vaginitis: no longer a stranger
  75. Clinical Validation of a Test for the Diagnosis of Vaginitis: Correction
  76. Clinical Validation of a Test for the Diagnosis of Vaginitis
  77. Lichen sclerosus in women: a review
  78. Survey on Aesthetic Vulvovaginal Procedures: What do Portuguese Doctors and Medical Students Think?
  79. Women without vulvodynia can have a positive ‘Q-tip test’: a cross sectional study
  80. P-04-003 Prevalence of Sexually Transmitted Diseases Among Women in Principe Island
  81. Deconstructing the genitourinary syndrome of menopause
  82. Genital Tract Infections in an Isolated Community: 100 Women of the Príncipe Island
  83. Is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504)
  84. Is the DSM-V Leading to the Nondiagnosis of Vulvodynia?
  85. Lipschütz ulcers: should we rethink this? An analysis of 33 cases
  86. Bacterial vaginosis and inflammatory response showed association with severity of cervical neoplasia in HPV-positive women
  87. Bacterial vaginosis, aerobic vaginitis, vaginal inflammation and major Pap smear abnormalities
  88. The “Genitourinary Syndrome of Menopause”
  89. Emphysematous Vaginitis
  90. What Differentiates Symptomatic from Asymptomatic Women with Lichen Sclerosus?
  91. Prevalence of vulvodynia and risk factors for the condition in Portugal
  92. Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism
  93. Mycoplasma pneumoniae
  94. Lichen Sclerosus in Breast Cancer Survivor
  95. Ovarian intratumoral 21-hydroxylase deficiency in a postmenopausal hirsute woman
  96. Sclerosing stromal tumour of the ovary associated with Meigs' syndrome and elevated CA125
  97. Case report: intra-partum utero-ovarian vessels rupture
  98. Use of extensible internal device in the femur of young dogs
  99. L-band land mobile satellite (LMS) amplitude and multipath phase modeling in urban areas
  100. Mobile and Base Station Diversity Simulation Experiments in a Mobile Communications Course